Dr. Daud on Interferon Gamma as a Biomarker in Melanoma
November 8th 2019Adil Daud, MD, clinical professor, Department of Medicine (Hematology/Oncology) and director, Melanoma Clinical Research, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses research evaluating interferon gamma as a potential biomarker of response in melanoma.
Read More
Dr. Daud on Challenges Facing the Treatment Landscape for Melanoma
October 19th 2017Adil Daud, MD, clinical professor, Department of Medicine, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses challenges facing the treatment landscape of melanoma.
Read More
Dr. Daud Discusses the Current Status of Immunotherapy in Melanoma
August 28th 2017Adil Daud, MD, clinical professor, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, at University of California, San Francisco, discusses the current status of immunotherapy in melanoma.
Read More
Dr. Daud on the Combinations of Immunotherapy for Melanoma
July 6th 2017Adil Daud, MD, a clinical professor, Department of Medicine at University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses potential combinations of immunotherapy for the treatment of patients with melanoma.
Read More